XML 45 R35.htm IDEA: XBRL DOCUMENT

SEGMENT INFORMATION (Tables)

9 Months Ended

Sep. 30, 2019

Segment Reporting [Abstract]

Schedule of Segment Reporting Information

The segment information is summarized as follows:

Business Segment Assets



		September 30, 2019				December 31, 2018
Human Nutrition & Health		$	692,558			$	702,692
Animal Nutrition & Health		136,680				136,810
Specialty Products		182,002				59,558
Industrial Products		15,590				22,822
Other Unallocated ⁽¹⁾		69,798				59,473
Total		$	1,096,628			$	981,355

⁽¹⁾ Other unallocated assets consist of certain cash, capitalized loan issuance costs, other assets, investments, and deferred income taxes, which the Company does not allocate to its individual business segments.

Business Segment Net Sales



		Three Months Ended September 30,								Nine Months Ended September 30,
		2019				2018				2019				2018
Human Nutrition & Health		$	86,142			$	85,890			$	257,163			$	253,966
Animal Nutrition & Health		42,286				40,410				129,127				128,587
Specialty Products		24,888				17,629				68,219				58,233
Industrial Products		5,279				11,114				22,669				39,354
Total		$	158,595			$	155,043			$	477,178			$	480,140

Business Segment Earnings Before Income Taxes



		Three Months Ended September 30,								Nine Months Ended September 30,
		2019				2018				2019				2018
Human Nutrition & Health		$	13,193			$	13,107			$	39,234			$	35,724
Animal Nutrition & Health		6,122				5,100				16,423				19,607
Specialty Products		6,699				5,767				22,275				19,476
Industrial Products		842				1,751				3,390				6,843
Transaction and integration costs, ERP implementation costs, and unallocated legal fees ⁽²⁾		(688		)		(202		)		(2,253		)		(1,784		)
Unallocated amortization expense ⁽³⁾		(138		)		—				(157		)		—
Interest and other (expense) ⁽⁴⁾		(1,594		)		(1,994		)		(4,802		)		(6,099		)
Total		$	24,436			$	23,529			$	74,110			$	73,767

⁽²⁾ Transaction and integration costs and unallocated legal fees for the three and nine month ended September 30, 2019 and 2018, respectively, were primarily related to acquisitions. ERP implementation costs for the three and nine months ended September 30, 2019 and 2018 were related to a project in connection with a company-wide ERP system implementation.
⁽³⁾ Unallocated amortization expense for the three and nine months ended September 30, 2019 was related to amortization of an intangible asset in connection with a company-wide ERP system implementation.
⁽⁴⁾ Interest and other (expense) for the three and nine months ended September 30, 2019 and 2018 included amortization expense related to capitalized loan issuance costs.

Depreciation/Amortization



		Three Months Ended September 30,								Nine Months Ended September 30,
		2019				2018				2019				2018
Human Nutrition & Health		$	7,411			$	8,372			$	22,880			$	25,288
Animal Nutrition & Health		1,646				1,397				4,847				3,996
Specialty Products		2,372				1,019				4,983				3,039
Industrial Products		116				176				406				527
Unallocated amortization expense ⁽⁵⁾		$	138			$	—			$	157			$	—
Amortization expense related to deferred financing cost ⁽⁶⁾		$	70			$	70			$	212			$	610
Total		$	11,753			$	11,034			$	33,485			$	33,460

⁽⁵⁾ Unallocated amortization expense for the three and nine months ended September 30, 2019 was related to amortization of an intangible asset in connection with a company-wide ERP system implementation.
⁽⁶⁾ Amortization expense related to capitalized loan issuance costs was included in interest and other (expense) in Company's condensed consolidated statement of earnings.

Capital Expenditures



		Nine Months Ended September 30,
		2019				2018
Human Nutrition & Health		$	14,136			$	6,041
Animal Nutrition & Health		2,788				3,002
Specialty Products		2,050				1,376
Industrial Products		583				909
Total		$	19,557			$	11,328